Middlesex Hospital was a teaching hospital located in the Fitzrovia area of London, England. First opened as the Middlesex Infirmary in 1745 on Windmill Street, it was moved in 1757 to Mortimer Street where it remained until it was finally closed in 2005.

During the past decade, Middlesex Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 5 clinical trials were completed, i.e. on average, 26.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Middlesex Hospital" #1 sponsor was "Children's Cancer and Leukaemia Group" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "European Paediatric Soft Tissue Sarcoma Study Group" with 2 trials sponsored and "Incyte Corporation" with 2 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Middlesex Hospital" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Cancer Research UK" with 2 trials as a collaborator, "Children's Cancer and Leukaemia Group" with 2 trials as a collaborator, "Dutch Childhood Oncology Group" with 2 trials as a collaborator and "Italian Association for Pediatric Hematology Oncology" with 2 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Middlesex Hospital" are "Lymphoma" (5 trials), "Sarcoma" (4 trials), "Brain and Central Nervous System Tumors" (3 trials), "Uterine Fibroids" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Middlesex Hospital" in a lesser frequency.

Most popular intervention types in "Middlesex Hospital" are "Drug" (28 trials), "Procedure" (11 trials), "Radiation" (9 trials), "Other" (7 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "doxorubicin hydrochloride" (5 trials), "etoposide" (5 trials), "radiation therapy" (5 trials) and "carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Middlesex Hospital" are 39 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Middlesex Hospital". 1 are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Middlesex Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Middlesex Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".

Middlesex Hospital has several departments that took part in Clinical trials: "Helen Rollason Cancer Care Centre at North Middlesex Hospital" - 11 trials